The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvingtrans Regulatory News (AVG)

Share Price Information for Avingtrans (AVG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 425.00
High: 425.00
Low: 425.00
Prev. Close: 425.00
AVG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Notice of Results

7 Jul 2022 07:00

RNS Number : 5778R
Avingtrans PLC
07 July 2022
 

7 July 2022

Avingtrans Plc

("Avingtrans", the "Company", or the "Group")

Trading Update and Notice of Results

Avingtrans PLC (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, announces a trading update in respect of the financial year ended 31 May 2022.

The Board is pleased to report that the results for the year ended 31 May 2022 are expected to be in line with market expectations. The Group's year end net cash position was strong, standing at in excess of £16 million (excluding IFRS 16), following investments in the period in Magnetica, Adaptix and Transkem, compared to £23 million as at 31 May 2021. The Group's order and prospect pipeline also remains strong.

Hayward Tyler, Inc. has secured a contract extension for the continued development of next generation molten salt pumps, under the Advanced Reactor Demonstration Program, valued at US $1.1m. This recent contract extends the program value beyond $2.5 million since June 2021. In addition to the contract extension, Hayward Tyler, Inc. became the first US company to update its ASME "N" Certifications to include Section III, Division 5 equipment. This section of the code allows for design, manufacture, and inspection of pumps and process equipment for advanced, high temperature nuclear reactors.

Avingtrans partner company, Adaptix, has filed its 510(k) premarket notification with the US FDA - allowing the company to begin marketing its Point-of-Care 3D orthopedic system in the United States. Adaptix has developed novel technologies that allow affordable, low-dose 3D imaging at the Point-of-Care using Digital Tomosynthesis (DT), to provider quicker, more accurate diagnosis possibilities. This is a significant milestone for Adaptix and trailblazes the path for Magnetica.

The Company is also pleased to have received an award for 'Transaction of the Year', in relation to the disposal of Peter Brotherhood in 2021, at the annual Small Cap Awards ceremony 2022. The Company has been judged amongst the best companies and participants in the small and micro-cap community across thirteen categories recognising outstanding achievement. The award is welcome recognition of the Group's successful PIE strategy, which aims to maximise shareholder value over the long term.

Notice of Results

Avingtrans will publish its results for the twelve months ended 31 May 2022 on 28 September 2022. 

The management team will be hosting a presentation for analysts on the day of results - for more information please contact Zach Cohen at IFC Advisory on zach.cohen@investor-focus.co.uk

Steve McQuillan, CEO of Avingtrans, commented:

"We are very pleased with the performance of the Group, overcoming many challenges and working tirelessly to report results for the year ended 31 May 2022 in line with market expectations. The Company has entered the new financial year with continued momentum, with strategic progress continuing and a robust pipeline of opportunites setting the foundations for solid growth for the coming year."

Enquiries:

Avingtrans plc

01354 692391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

 

Singer Capital Markets (Nominated Adviser and Broker)

02074 963000

Shaun Dobson

Alex Bond

Oliver Platts

Rachel Hayes

 

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

 

 

About Avingtrans plc: 

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide. 

Business units

Hayward Tyler - Luton & East Kilbride, UK and USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

Energy Steel, Inc - Rochester Hills, Michigan, USA

Energy Steel, part of the Engineered Pumps and Motors Division of Avingtrans plc, has been serving the nuclear power industry since 1982 with capabilities in equipment fabrication, material supply, precision machining, engineering, and repair services. Through strategic OEM partnerships, it also provides solutions for obsolete nuclear components and support for the most complex projects. 

Stainless Metalcraft Ltd - Chatteris, UK and Chengdu, China

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast &explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above

Ormandy Group, Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments. 

Tecmag Inc, Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRFMATMTBMBRT
Date   Source Headline
30th Jun 20167:00 amRNSUpdate on Return of funds to Shareholders
21st Jun 20162:10 pmRNSHolding(s) in Company
1st Jun 20167:00 amRNSChange of Registered Office
31st May 20165:20 pmRNSExercise of Share Options - Correction
31st May 20165:10 pmRNSHolding(s) in Company
27th May 20162:07 pmRNSCompletion of Disposal
26th May 20161:53 pmRNSExercise of Share Options
25th May 201612:45 pmRNSResult of General Meeting
5th May 20167:00 amRNSHolding(s) in Company
4th May 20167:00 amRNSProposed Disposal and Notice of General Meeting
15th Mar 20168:25 amRNSExercise of Share Options
7th Mar 20167:00 amRNSSigma signs £75m deal with Rolls-Royce
4th Mar 20167:00 amRNSCompletion of Acquisition
25th Feb 20167:00 amRNSHolding(s) in Company
17th Feb 20167:00 amRNSInterim Results
15th Feb 20167:00 amRNSNew Contract Win and Framework Agreements
29th Jan 20167:00 amRNSAcquisition of pipe manufacturing business
11th Dec 201511:10 amRNSExercise of Share Options
4th Nov 20157:00 amRNSJGC Gulf International contract win
21st Oct 20151:05 pmRNSExercise of Share Options
30th Sep 20157:00 amRNSFinal Results
1st Sep 201511:00 amRNSHolding(s) in Company
6th Jul 20157:00 amRNSSale of Aldridge Site
19th Jun 20157:00 amRNSSigma signs £5m contract with Sonaca
27th May 20158:58 amRNSExercise of Options
11th May 20157:00 amRNSStainless Metalcraft secures contract
14th Apr 20158:33 amRNSMaloney Metalcraft secures Samsung contract
14th Apr 20157:00 amRNSMaloney Metalcraft secures Samsung contract
25th Feb 20151:43 pmRNSDirector/PDMR Shareholding
25th Feb 20157:00 amRNSHalf Yearly Report
17th Feb 20157:00 amRNSNotice of Results
11th Dec 20147:00 amRNSAward of Options
2nd Dec 20147:00 amRNSExercise of Share Options
27th Nov 20147:00 amRNSLong Term Airbus Contract Announcement
24th Nov 20147:00 amRNSTrading Update
12th Nov 20141:40 pmRNSResult of AGM
12th Nov 20148:40 amRNSHolding(s) in Company
30th Oct 20147:00 amRNSDirector/PDMR Shareholding
1st Oct 20147:00 amRNSFinal Results
11th Aug 20143:10 pmRNSCompletion of RMDG Aerospace Acquisition
6th Aug 20147:00 amRNSAcquisition of RMDG
4th Aug 20147:00 amRNSBoard Appointment
30th Jul 20147:00 amRNSDivisional Board Appointment
3rd Jun 20142:41 pmRNSDirector/PDMR Shareholding
3rd Jun 20142:40 pmRNSHolding(s) in Company
2nd Apr 20147:00 amRNSContract Win
26th Feb 20147:00 amRNSInterim Results
16th Dec 201312:15 pmRNSDirector/PDMR Shareholding
22nd Nov 20134:45 pmRNSAward of Options, Issue of Equity and TVR
7th Nov 20135:22 pmRNSExercise of Share Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.